KR20240158385A - 대기 오염의 악영향을 막는 수용성 토마토 추출물 - Google Patents
대기 오염의 악영향을 막는 수용성 토마토 추출물 Download PDFInfo
- Publication number
- KR20240158385A KR20240158385A KR1020247035927A KR20247035927A KR20240158385A KR 20240158385 A KR20240158385 A KR 20240158385A KR 1020247035927 A KR1020247035927 A KR 1020247035927A KR 20247035927 A KR20247035927 A KR 20247035927A KR 20240158385 A KR20240158385 A KR 20240158385A
- Authority
- KR
- South Korea
- Prior art keywords
- wste
- air pollution
- risk
- cardiovascular health
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003915 air pollution Methods 0.000 title claims abstract description 57
- 239000000284 extract Substances 0.000 title claims abstract description 33
- 235000007688 Lycopersicon esculentum Nutrition 0.000 title claims abstract description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 8
- 230000000694 effects Effects 0.000 title claims description 20
- 240000003768 Solanum lycopersicum Species 0.000 title abstract description 18
- 230000002411 adverse Effects 0.000 title description 6
- 239000000203 mixture Substances 0.000 claims abstract description 40
- 230000036996 cardiovascular health Effects 0.000 claims abstract description 38
- 208000010110 spontaneous platelet aggregation Diseases 0.000 claims description 38
- 239000002245 particle Substances 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- 235000013305 food Nutrition 0.000 claims description 11
- 230000003405 preventing effect Effects 0.000 claims description 11
- 230000036541 health Effects 0.000 claims description 9
- 235000013376 functional food Nutrition 0.000 claims description 8
- 235000015872 dietary supplement Nutrition 0.000 claims description 7
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 6
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 6
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 6
- 229960004999 lycopene Drugs 0.000 claims description 6
- 235000012661 lycopene Nutrition 0.000 claims description 6
- 239000001751 lycopene Substances 0.000 claims description 6
- -1 phenol ester Chemical class 0.000 claims description 6
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229930003935 flavonoid Natural products 0.000 claims description 3
- 150000002215 flavonoids Chemical class 0.000 claims description 3
- 235000017173 flavonoids Nutrition 0.000 claims description 3
- 239000002777 nucleoside Substances 0.000 claims description 3
- 239000002417 nutraceutical Substances 0.000 claims description 3
- 235000021436 nutraceutical agent Nutrition 0.000 claims description 3
- 239000000428 dust Substances 0.000 claims description 2
- 150000003833 nucleoside derivatives Chemical class 0.000 claims description 2
- 150000007965 phenolic acids Chemical class 0.000 claims description 2
- 239000000779 smoke Substances 0.000 claims description 2
- 230000000391 smoking effect Effects 0.000 claims description 2
- 241000227653 Lycopersicon Species 0.000 claims 8
- 239000002552 dosage form Substances 0.000 claims 8
- 239000013618 particulate matter Substances 0.000 description 54
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 32
- 235000014678 Fruitflow® Nutrition 0.000 description 21
- 230000002776 aggregation Effects 0.000 description 18
- 238000004220 aggregation Methods 0.000 description 15
- 230000010118 platelet activation Effects 0.000 description 11
- 208000024172 Cardiovascular disease Diseases 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 201000001320 Atherosclerosis Diseases 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 210000004623 platelet-rich plasma Anatomy 0.000 description 6
- 229910010413 TiO 2 Inorganic materials 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 4
- 229910002651 NO3 Inorganic materials 0.000 description 4
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000000748 cardiovascular system Anatomy 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 230000009257 reactivity Effects 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 238000005054 agglomeration Methods 0.000 description 3
- 239000000556 agonist Substances 0.000 description 3
- 230000000702 anti-platelet effect Effects 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 206010003178 Arterial thrombosis Diseases 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 235000003228 Lactuca sativa Nutrition 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 208000005764 Peripheral Arterial Disease Diseases 0.000 description 2
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- 239000000809 air pollutant Substances 0.000 description 2
- 231100001243 air pollutant Toxicity 0.000 description 2
- 230000002744 anti-aggregatory effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000003727 cerebral blood flow Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 235000021056 liquid food Nutrition 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 235000020124 milk-based beverage Nutrition 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 235000014214 soft drink Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 235000010215 titanium dioxide Nutrition 0.000 description 2
- DUSLRMWWOOPYOW-ABLWVSNPSA-N (2S)-2-[[4-[(2-amino-5-methoxy-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid Chemical compound O(C)N1C=2C(NC(=NC=2NCC1CNC1=CC=C(C(N[C@@H](CCC(=O)O)C(=O)O)=O)C=C1)N)=O DUSLRMWWOOPYOW-ABLWVSNPSA-N 0.000 description 1
- MSTNYGQPCMXVAQ-RYUDHWBXSA-N (6S)-5,6,7,8-tetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1)N)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-RYUDHWBXSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920001732 Lignosulfonate Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 230000007211 cardiovascular event Effects 0.000 description 1
- 230000005800 cardiovascular problem Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000012182 cereal bars Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000007402 cytotoxic response Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000002283 diesel fuel Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000008393 encapsulating agent Substances 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000014106 fortified food Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000015122 lemonade Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000008288 physiological mechanism Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000013606 potato chips Nutrition 0.000 description 1
- 235000019684 potato crisps Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 230000009863 secondary prevention Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006068 taste-masking agent Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000005460 tetrahydrofolate Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical class OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 235000008924 yoghurt drink Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2116—Flavonoids, isoflavones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16196794.8 | 2016-11-02 | ||
| EP16196794 | 2016-11-02 | ||
| PCT/EP2017/077993 WO2018083137A1 (en) | 2016-11-02 | 2017-11-02 | Water soluble tomato extract protects against adverse effects of air pollution |
| KR1020237010833A KR20230048169A (ko) | 2016-11-02 | 2017-11-02 | 대기 오염의 악영향을 막는 수용성 토마토 추출물 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020237010833A Division KR20230048169A (ko) | 2016-11-02 | 2017-11-02 | 대기 오염의 악영향을 막는 수용성 토마토 추출물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20240158385A true KR20240158385A (ko) | 2024-11-04 |
Family
ID=57223556
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020247035927A Pending KR20240158385A (ko) | 2016-11-02 | 2017-11-02 | 대기 오염의 악영향을 막는 수용성 토마토 추출물 |
| KR1020197015838A Ceased KR20190101964A (ko) | 2016-11-02 | 2017-11-02 | 대기 오염의 악영향을 막는 수용성 토마토 추출물 |
| KR1020237010833A Ceased KR20230048169A (ko) | 2016-11-02 | 2017-11-02 | 대기 오염의 악영향을 막는 수용성 토마토 추출물 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020197015838A Ceased KR20190101964A (ko) | 2016-11-02 | 2017-11-02 | 대기 오염의 악영향을 막는 수용성 토마토 추출물 |
| KR1020237010833A Ceased KR20230048169A (ko) | 2016-11-02 | 2017-11-02 | 대기 오염의 악영향을 막는 수용성 토마토 추출물 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US10905733B2 (enExample) |
| EP (2) | EP3534725A1 (enExample) |
| JP (1) | JP7104032B2 (enExample) |
| KR (3) | KR20240158385A (enExample) |
| CN (2) | CN109890223A (enExample) |
| AU (1) | AU2017353349B2 (enExample) |
| BR (1) | BR112019008687B1 (enExample) |
| CA (1) | CA3042720A1 (enExample) |
| IL (1) | IL266397B (enExample) |
| MX (1) | MX2019005054A (enExample) |
| MY (1) | MY199636A (enExample) |
| PH (1) | PH12019500953A1 (enExample) |
| TW (1) | TWI837080B (enExample) |
| WO (1) | WO2018083137A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2844083T3 (pl) | 2012-04-23 | 2018-12-31 | University Of Oslo | Zastosowanie ekstraktu pomidorowego jako środka przeciwdziałającego nadciśnieniu i proces do sporządzania rozpuszczalnego w wodzie ekstraktu pomidorowego bez cukru |
| GB201223365D0 (en) | 2012-12-24 | 2013-02-06 | Provexis Natural Products Ltd | Compositions |
| MX2019005054A (es) | 2016-11-02 | 2019-06-20 | Provexis Natural Products Ltd | Extracto de jitomate soluble en agua protege contra los efectos adversos de la contaminacion del aire. |
| GB202208323D0 (en) | 2022-06-07 | 2022-07-20 | Provexis Natural Products Ltd | Compostions |
| CN116688025A (zh) * | 2023-06-21 | 2023-09-05 | 汤臣倍健股份有限公司 | 水溶性番茄浓缩物在制备治疗脑缺血—再灌注损伤的组合物中的应用 |
| CN116803404B (zh) * | 2023-08-24 | 2023-12-15 | 汤臣倍健股份有限公司 | 水溶性番茄浓缩物在制备减少脱发、育发的产品中的应用 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6467173A (en) | 1987-09-04 | 1989-03-13 | Sanei Kagaku Kogyo Kk | Preparation of vegetable or fruit juices |
| JP2722670B2 (ja) | 1989-05-30 | 1998-03-04 | ライオン株式会社 | 高血圧症予防用飲食品及びその製造方法 |
| JP2997358B2 (ja) | 1992-01-30 | 2000-01-11 | ポーラ化成工業株式会社 | 皮膚外用剤 |
| DK0656881T3 (da) | 1992-07-30 | 1999-06-23 | Cal Int Ltd | Ester og kombinationer af et organisk nitrat og et salicylat |
| US5502038A (en) | 1993-06-21 | 1996-03-26 | Medical Research Foundation Of Oregon | Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption |
| JP2905725B2 (ja) | 1995-07-01 | 1999-06-14 | カゴメ株式会社 | トマト由来の食品組成物 |
| FR2759904B1 (fr) | 1997-02-25 | 2000-01-28 | Alma Heny Reza | Compositions a usage cosmetique et/ou pharmaceutique et/ou dermatologique et leurs procedes de fabrication |
| DE19720767A1 (de) | 1997-05-07 | 1998-11-12 | Protekum Umweltinstitut Gmbh O | Pharmazeutisches Produkt, insbesondere zur Therapie und Prophylaxe von Herz-Kreislauf-Erkrankungen |
| GB9808796D0 (en) | 1998-04-24 | 1998-06-24 | Rowett Research Services Limit | Antithrombotic agents |
| DE69907342T2 (de) | 1998-09-02 | 2004-03-25 | Unilever N.V. | Mit beta-cyclocitral angereicherte Tomatenprodukte |
| AU5965399A (en) | 1998-10-12 | 2000-05-01 | Andreas Bockelmann | Pharmaceutically active composition |
| CN1352941A (zh) | 2000-11-11 | 2002-06-12 | 吉建军 | 亚油酸胶囊 |
| WO2002090386A2 (en) | 2001-05-04 | 2002-11-14 | Ato B.V. | Regulatory protein involved in pectin modification |
| DE10300049A1 (de) | 2003-01-03 | 2004-07-15 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen, die Faktor VIIa inhibieren |
| ITMI20020632A1 (it) | 2002-03-27 | 2003-09-29 | Indena Spa | Processo per la preparazione di estratti di pomodoro ad elevato contenuto di licopene |
| EP1559421B1 (en) | 2002-11-06 | 2016-07-27 | Kao Corporation | Blood circulation promoting agent |
| JP4684893B2 (ja) | 2003-03-27 | 2011-05-18 | ユニジェン インク． | 炎症性及び血液循環疾患の治療及び予防活性を示す、竹抽出物並びにそれから分離された化合物を含有する組成物 |
| JP4571783B2 (ja) | 2003-04-14 | 2010-10-27 | 林原 健 | 抗微生物剤 |
| US20040223962A1 (en) | 2003-05-07 | 2004-11-11 | Riordan Neil H. | Method and composition for preventing or reducing edema, deep vein thrombosis and/or pulmonary embolism |
| EP1481669A1 (en) | 2003-05-30 | 2004-12-01 | Yamanouchi Pharmaceutical Co. Ltd. | Use of polyhydroxy phenols and polyphenols for modulating p-selectin activity |
| ES2322757T3 (es) | 2003-08-21 | 2009-06-26 | Nestec S.A. | Concentrado natural de licopeno y procedimiento de obtencion. |
| JP2004137287A (ja) | 2003-12-08 | 2004-05-13 | Kao Corp | 高血圧症予防・治療剤 |
| FR2871378B1 (fr) | 2004-06-15 | 2007-03-30 | Seppic Sa | Nouveau medicament a base de flavanois et de leurs derives et son utilisation pour obtenir un medicament destine a la prevention de la restenose et de la maladie atheromateuse chez les patients coronariens |
| EP1640001A1 (en) | 2004-09-24 | 2006-03-29 | New Pharma Investments Holding | Composition against cardiovascular diseases |
| CN100488535C (zh) | 2004-12-09 | 2009-05-20 | 郭富凤 | 一种番茄红素混合物 |
| US7419960B2 (en) | 2005-01-07 | 2008-09-02 | Hong Kong Baptist University | Hemiterpene glycosides with anti-platelet aggregation activities from Ilex pubescens |
| JP2006193435A (ja) | 2005-01-11 | 2006-07-27 | Kagome Co Ltd | 疲労改善剤 |
| GB0502985D0 (en) | 2005-02-14 | 2005-03-16 | Provexis Ltd | Therapeutic uses of tomato extracts |
| WO2006094120A2 (en) | 2005-03-02 | 2006-09-08 | The Regents Of The University Of California | Treatment for embolic stroke |
| JP4260158B2 (ja) | 2005-07-07 | 2009-04-30 | 長谷川香料株式会社 | トマトジュース濃縮物の製造方法およびトマト風味組成物 |
| US20070082071A1 (en) * | 2005-10-07 | 2007-04-12 | Willimann John A | Composition for controlling the respiratory effects of inhaled pollutants & allergens |
| AT503521A1 (de) | 2006-05-05 | 2007-11-15 | Omnica Gmbh | Verwendung eines extraktes von kiwi-frucht |
| GB0610790D0 (en) | 2006-06-02 | 2006-07-12 | Provexis Natural Products Ltd | Therapeutic uses of tomato extracts |
| US20080009449A1 (en) | 2006-07-07 | 2008-01-10 | Kailash Prasad | Lignan complex derived from flax seed used for treatment of hypercholesterolemic atherosclerosis |
| SG191445A1 (en) | 2006-12-22 | 2013-07-31 | Univ Johns Hopkins | Anti-cholesterolemic compounds and methods of use |
| US8759327B2 (en) | 2007-04-16 | 2014-06-24 | The Regents Of The University Of Michigan | Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism |
| EP2036568A1 (en) | 2007-09-12 | 2009-03-18 | Nestec S.A. | Wolfberries and inflammation |
| JP2009240191A (ja) | 2008-03-31 | 2009-10-22 | Shimizu Shoko Kaigisho | 光照射によるリグナン類・リグニン類合成系遺伝子の発現増強 |
| GB0819958D0 (en) * | 2008-10-31 | 2008-12-10 | Provexis Natural Products Ltd | Therapeutic compositions |
| GB0819959D0 (en) * | 2008-10-31 | 2008-12-10 | Provexis Natural Products Ltd | Fruit extracts |
| CA2785581A1 (en) * | 2009-12-24 | 2011-06-30 | Stanley Kubow | Compositions and methods for preventing and treating diseases and environmentally induced health disorders |
| PL2844083T3 (pl) | 2012-04-23 | 2018-12-31 | University Of Oslo | Zastosowanie ekstraktu pomidorowego jako środka przeciwdziałającego nadciśnieniu i proces do sporządzania rozpuszczalnego w wodzie ekstraktu pomidorowego bez cukru |
| GB201223365D0 (en) | 2012-12-24 | 2013-02-06 | Provexis Natural Products Ltd | Compositions |
| MX2019005054A (es) | 2016-11-02 | 2019-06-20 | Provexis Natural Products Ltd | Extracto de jitomate soluble en agua protege contra los efectos adversos de la contaminacion del aire. |
-
2017
- 2017-11-02 MX MX2019005054A patent/MX2019005054A/es unknown
- 2017-11-02 US US16/346,013 patent/US10905733B2/en active Active
- 2017-11-02 EP EP17803808.9A patent/EP3534725A1/en not_active Withdrawn
- 2017-11-02 MY MYPI2019002434A patent/MY199636A/en unknown
- 2017-11-02 JP JP2019522897A patent/JP7104032B2/ja active Active
- 2017-11-02 AU AU2017353349A patent/AU2017353349B2/en active Active
- 2017-11-02 KR KR1020247035927A patent/KR20240158385A/ko active Pending
- 2017-11-02 CA CA3042720A patent/CA3042720A1/en active Pending
- 2017-11-02 KR KR1020197015838A patent/KR20190101964A/ko not_active Ceased
- 2017-11-02 CN CN201780067811.5A patent/CN109890223A/zh active Pending
- 2017-11-02 EP EP24198362.6A patent/EP4445750A3/en active Pending
- 2017-11-02 CN CN202410362043.8A patent/CN118217345A/zh active Pending
- 2017-11-02 KR KR1020237010833A patent/KR20230048169A/ko not_active Ceased
- 2017-11-02 TW TW106137949A patent/TWI837080B/zh active
- 2017-11-02 IL IL266397A patent/IL266397B/en unknown
- 2017-11-02 BR BR112019008687-0A patent/BR112019008687B1/pt active IP Right Grant
- 2017-11-02 WO PCT/EP2017/077993 patent/WO2018083137A1/en not_active Ceased
-
2019
- 2019-04-29 PH PH12019500953A patent/PH12019500953A1/en unknown
-
2021
- 2021-01-04 US US17/140,570 patent/US20210299205A1/en not_active Abandoned
-
2024
- 2024-12-03 US US18/966,432 patent/US20250205299A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20210299205A1 (en) | 2021-09-30 |
| KR20230048169A (ko) | 2023-04-10 |
| IL266397A (en) | 2019-06-30 |
| EP3534725A1 (en) | 2019-09-11 |
| PH12019500953A1 (en) | 2019-08-05 |
| EP4445750A2 (en) | 2024-10-16 |
| US20250205299A1 (en) | 2025-06-26 |
| AU2017353349A1 (en) | 2019-06-06 |
| US20200054706A1 (en) | 2020-02-20 |
| WO2018083137A1 (en) | 2018-05-11 |
| JP2019532986A (ja) | 2019-11-14 |
| EP4445750A3 (en) | 2024-12-25 |
| CA3042720A1 (en) | 2018-05-11 |
| US10905733B2 (en) | 2021-02-02 |
| CN118217345A (zh) | 2024-06-21 |
| CN109890223A (zh) | 2019-06-14 |
| IL266397B (en) | 2022-08-01 |
| TW201821097A (zh) | 2018-06-16 |
| BR112019008687B1 (pt) | 2023-02-07 |
| AU2017353349B2 (en) | 2022-04-21 |
| BR112019008687A2 (pt) | 2019-07-09 |
| MX2019005054A (es) | 2019-06-20 |
| KR20190101964A (ko) | 2019-09-02 |
| MY199636A (en) | 2023-11-11 |
| JP7104032B2 (ja) | 2022-07-20 |
| TWI837080B (zh) | 2024-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250205299A1 (en) | Water soluble tomato extract protects against adverse effects of air pollution | |
| Samson et al. | Haematological and hepatotoxic potential of onion (Allium cepa) and garlic (Allium sativum) extracts in rats | |
| JPH11500725A (ja) | ピペリンのバイオアベイラビリティ増強剤としての使用 | |
| CA2564326A1 (en) | Nutritional composition which promotes weight loss, burns calories, increases thermogenesis, supports energy metabolism and/or suppresses appetite | |
| P. Karagodin et al. | Antiatherosclerotic and cardioprotective effects of time-released garlic powder pills | |
| US20120022018A1 (en) | Anti-viral properties of aloe vera and acquired immune deficiency syndrome (aids) treatment | |
| US8591965B2 (en) | Use of a ginkgo complexes for the enhancement of cognitive functions and the alleviation of mental fatigue | |
| US20070082064A1 (en) | Nutritional or dietary supplement for the treatment of macular degeneration | |
| KR100647722B1 (ko) | 감기 예방용 조성물 | |
| KR20160099972A (ko) | 번아웃증후군의 예방, 개선 또는 치료용 조성물 | |
| KR20250031575A (ko) | 수용성 토마토 추출물 | |
| US9867860B2 (en) | Formulations for preventing and treating decreasing platelet cell counts | |
| KR100437001B1 (ko) | 한방 건강식 다이어트 조성물 | |
| US11458150B2 (en) | Methylphosphinic acid compositions and methods for reducing aging | |
| JP2006022056A (ja) | 酒酔い防止剤 | |
| Yadav et al. | Review on preclinical and clinical evidence of food (Beverages, fruits and vegetables) and drug interactions: mechanism and safety | |
| RU2436415C2 (ru) | Композиция биологически активных веществ на основе бетулина с регулируемой скоростью высвобождения компонентов для снижения степени алкогольного опьянения, предупреждения и снятия алкогольной интоксикации и похмельного синдрома | |
| Ikese et al. | Effect of Telfaira occidentalis leaf extract on packed cell volume in rats with malaria-induced anaemia | |
| JP2006306897A (ja) | モズク由来フコイダン含有剤 | |
| WO2022024147A1 (en) | Compositions of lactoferrin whey protein and jackfruit seed powder | |
| CA2894914A1 (en) | Formulations for preventing and treating decreasing platelet cell counts | |
| Tori Hudson | Botanical Strategies for Metabolic Syndrome and Type 2 Diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A107 | Divisional application of patent | ||
| PA0104 | Divisional application for international application |
Comment text: Divisional Application for International Patent Patent event code: PA01041R01D Patent event date: 20241028 Application number text: 1020237010833 Filing date: 20230329 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20241126 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20241206 Patent event code: PE09021S01D |